Category Disability

Gene Therapy: A Threat to the Deaf Community?

Teresa Blankmeyer Burke considers the problematic nature of gene therapy research aimed at eliminating hereditary deafness.

Human germline genome editing: An ‘impressive’ sleight of hand?

Françoise Baylis wonders how it is that in 14 months (from December 2015 to February 2017), the U.S. National Academy of Sciences and the U.S. National Academy of Medicine have moved human germline genome editing out of the category ‘irresponsible’ and into the category ‘permissible.’

Lupron: Déjà Vu All Over Again

Alice Dreger raises concerns about a pervasive pattern of non-evidence based assumptions driving practices in pediatric endocrinology.

IVF, Multiples, and Risk: Buyer Beware

Janet Farrell Leontiou reflects on her experience as an IVF patient who was misled into choosing several multiple embryo transfers.

Limits on Medical Marijuana for Veterans

Chelsea Cox questions the federal government’s recent decision to limit reimbursement for the cost of medical marijuana used by veterans to three grams a day.

SickKids’ New Ad Campaign: Fighting words?

Michael Orsini and Anne McGuire offer a critical disability studies perspective on the Hospital for Sick Children’s latest ad campaign.

Risky Business: Genetic Discrimination & Insurance

Françoise Baylis discusses the response of the Canadian insurance industry to Bill S-201, An Act to prohibit and prevent genetic discrimination.